Previous close | 7.75 |
Open | 7.65 |
Bid | 7.45 x 0 |
Ask | 8.00 x 0 |
Day's range | 7.65 - 7.70 |
52-week range | 6.15 - 13.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEWPORT BEACH, Calif., March 08, 2023--Evolus reports financial results for the fourth quarter and full year ended December 31, 2022 and provides a business update
NEWPORT BEACH, Calif., February 28, 2023--Evolus announces that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida.
NEWPORT BEACH, Calif., February 27, 2023--Evolus commences the commercial launch of Nuceiva® in Germany and Austria, and is now available for direct order and delivery to customers.